The global creatinine meter market is poised for significant expansion, projected to grow at a robust CAGR of around 8% to 9% from 2022 to 2032. The market’s growth is largely driven by the increasing demand in the point-of-care segment, which is expected to account for sales of USD 1,250 million by 2032. With the growing need for efficient and swift diagnostic tools for chronic kidney diseases, creatinine meters are becoming essential in the healthcare sector.
Key Takeaways:
- Market Growth: The global creatinine meter market is anticipated to grow at a CAGR of 8% to 9% during the forecast period 2022-2032.
- Point-of-Care Segment: This segment is expected to be highly lucrative, reaching USD 1,250 million by 2032, up from USD 650 million in 2022.
- Demand Drivers: The demand for creatinine meters is fueled by the need for quick and precise diagnostic tools for chronic kidney diseases, avoiding delays and risks associated with traditional lab tests.
- Challenges: High costs and the need for skilled professionals to operate creatinine meters pose challenges to market growth. The availability of low-cost alternatives also hampers demand.
- Regional Insights: North America and Europe are emerging as key markets, driven by high prevalence of kidney diseases and advanced healthcare infrastructure.
Request Your Sample and Stay Ahead with Our Insightful Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-9240
Market Overview: Creatinine meters are critical medical devices used for diagnosing and monitoring chronic kidney diseases, such as glomerulonephritis, kidney stones, polycystic kidney disease, and chronic intrinsic kidney failures. These devices measure blood creatinine levels, providing essential data for the management of kidney and renal disorders.
Drivers of Market Growth: The traditional process of testing creatinine levels in clinical labs is time-consuming and risky, especially due to the use of imaging agents like iodine and barium. Creatinine meters, particularly handheld devices, offer a solution by providing precise results within minutes, thus driving a shift towards their adoption in the healthcare sector globally. This swift, accurate testing capability is bolstering demand for creatinine meters.
Challenges in the Market: Despite their advantages, creatinine meters are costly and require skilled professionals for operation, which limits their widespread adoption. Additionally, the market faces competition from low-cost creatinine testing solutions, further challenging the growth of high-end creatinine meters.
Regional Insights:
- North America: North America is forecasted to be the most lucrative market for creatinine meters from 2022 to 2032. The demand is driven by increased usage in renal dialysis monitoring and blood and urine analyte measurement. Leading players are launching innovative products to meet this demand. For instance, in 2022, Nova Biomedical introduced the Nova Max Pro Creatinine/eGFR Meter System for early detection of kidney disease in point-of-care settings, highlighting the region’s focus on innovation and patient care.
- Europe: Europe is expected to exhibit rapid growth in the global creatinine meter market. The rising incidence of chronic kidney diseases due to lifestyle changes, obesity, and smoking is a significant driver. According to the Kidney Care Organization, around 10% of the U.K. population suffers from chronic kidney diseases. This high prevalence is boosting the demand for creatinine meters for diagnosis and treatment, thus propelling market growth in Europe.
Reach out to Sales to Secure Your Copy of the Report Now! https://www.futuremarketinsights.com/checkout/9240
Key Companies Profiled
Thermo Fisher Scientific; Hitachi; Siemens Healthcare GmbH; Randox Laboratories; Abbott; Nova Biomedical; Pointe Scientific; Diasys Diagnostic Systems GmbH; Sentinel Ch. Spa.; Others
Key Segments Profiled in the Creatinine Meter Market Survey
By Product:
- Creatinine Meters
- Reagents
- Sensor Strips & Kits
By Modularity:
- Handheld
- Desktop
By End Use:
- Point of Care Use
- Hospitals
- Diagnostic Laboratories
- Others
By Region:
- North America
- Latin America
- Europe
- CIS & Russia
- APEJ
- Japan
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube